Stoke Therapeutics, Inc.
STOK
35 insider filings · Latest: Aug 3, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Mar 19 9:57 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Sale | 4,628 | $31.34 | $145.1K | 28,836(D) | View → |
| Mar 17, 2026 | Mar 19 9:57 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Sale | 4,267 | $33.01 | $140.8K | 33,464(D) | View → |
| Mar 19, 2026 | Mar 19 8:19 PM | BARUCH S. TICHO | Proposed Sale | 1,461 | $31.02 | $45.3K | — | View → |
| Mar 13, 2026 | Mar 17 9:23 PM | LEVIN ARTHUR ADirector | Sale | 605 | $36.80 | $22.3K | 4,237(D) | View → |
| Mar 13, 2026 | Mar 13 8:19 PM | ARTHUR A LEVIN | Proposed Sale | 605 | $36.48 | $22.1K | — | View → |
| Mar 10, 2026 | Mar 12 8:57 PM | Arthur TzianabosDirector, Interim Executive Chair | Sale | 4,355 | $40.00 | $174.2K | 31,339(D) | View → |
| Mar 10, 2026 | Mar 12 8:56 PM | Adrian R. KrainerDirector | Sale | 33,243 | $39.74 | $1.3M | 283,302(D) | View → |
| Mar 10, 2026 | Mar 10 8:39 PM | ARTHUR TZIANABOS | Proposed Sale | 90,508 | $38.31 | $3.5M | — | View → |
| Mar 2, 2026 | Mar 4 9:28 PM | Adrian R. KrainerDirector | Sale | 7,229 | $39.66 | $286.7K | 316,545(D) | View → |
| Mar 2, 2026 | Mar 2 9:42 PM | Adrian Krainer | Proposed Sale | 40,472 | $36.41 | $1.5M | — | View → |
| Dec 8, 2025 | Dec 8 9:40 PM | EDWARD M KAYE | Proposed Sale | 13,430 | $30.87 | $414.6K | — | View → |
| Dec 8, 2025 | Dec 8 9:38 PM | JONATHAN ALLAN | Proposed Sale | 3,978 | $30.87 | $122.8K | — | View → |
| Dec 5, 2025 | Dec 5 9:38 PM | EDWARD M KAYE | Proposed Sale | 2,181 | $31.05 | $67.7K | — | View → |
| Dec 5, 2025 | Dec 5 9:29 PM | JONATHAN ALLAN | Proposed Sale | 7,781 | $31.05 | $241.6K | — | View → |
| Dec 5, 2025 | Dec 5 9:29 PM | BARUCH TICHO | Proposed Sale | 1,989 | $31.05 | $61.8K | — | View → |
| Nov 24, 2025 | Nov 24 9:24 PM | Adrian Krainer | Proposed Sale | 40,472 | $29.34 | $1.2M | — | View → |
| Nov 14, 2025 | Nov 14 9:29 PM | Adrian Krainer | Proposed Sale | 40,472 | $26.07 | $1.1M | — | View → |
| Nov 3, 2025 | Nov 3 9:22 PM | BARUCH TICHO | Proposed Sale | 5,931 | $30.04 | $178.2K | — | View → |
| Oct 8, 2025 | Oct 8 8:20 PM | EDWARD M KAYE | Proposed Sale | 25,000 | $27.31 | $682.8K | — | View → |
| Oct 3, 2025 | Oct 3 8:35 PM | EDWARD M KAYE | Proposed Sale | 42,461 | $24.82 | $1.1M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Feb 19 9:22 PM | Thomas LeggettChief Financial Officer | Grant/Award | 100,000 | $31.09 | 40,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:21 PM | Jason HoittChief Patient Officer | Grant/Award | 120,000 | $31.09 | 48,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:20 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Grant/Award | 88,000 | $31.09 | 35,000(D) | View → |
← Previous
Page 2 of 2